02.09.2005 19:00:00
|
Amgen Names Phyllis Piano Vice President, Corporate Communications and Philanthropy
Piano joins Amgen after serving as vice president, CorporateAffairs and Communications at Raytheon Company, a $20 billionaerospace and defense company, and a member of Raytheon's leadershipteam. Prior to joining Raytheon, she served as vice president, PublicAffairs for Cooper Industries, Inc., a manufacturer of electricalproducts, tools and hardware, and automotive products. Piano alsospent 17 years at General Electric where she progressed throughpositions of increasing responsibility in communications, includingher role as head of communications at GE Medical Systems.
About Amgen
Amgen discovers, develops and delivers innovative humantherapeutics. A biotechnology pioneer since 1980, Amgen was one of thefirst companies to realize the new science's promise by bringing safeand effective medicines from lab, to manufacturing plant, to patient.Amgen therapeutics have changed the practice of medicine, helpingmillions of people around the world in the fight against cancer,kidney disease, rheumatoid arthritis, and other serious illnesses.With a broad and deep pipeline of potential new medicines, Amgenremains committed to advancing science to dramatically improvepeople's lives. To learn more about our pioneering science and ourvital medicines, visit www.amgen.com.
EDITOR'S NOTE: An electronic version of this news release may beaccessed via our Web site at www.amgen.com. Journalists and mediarepresentatives may sign up to receive all news releaseselectronically at time of announcement by filling out a short form inthe Media section of the Web site.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Amgen Inc.mehr Nachrichten
17.02.25 |
Dow Jones 30 Industrial-Papier Amgen-Aktie: So viel Gewinn hätte ein Amgen-Investment von vor 5 Jahren eingefahren (finanzen.at) | |
14.02.25 |
Minuszeichen in New York: Dow Jones schlussendlich leichter (finanzen.at) | |
14.02.25 |
Verluste in New York: Dow Jones präsentiert sich am Nachmittag schwächer (finanzen.at) | |
14.02.25 |
Freitagshandel in New York: Dow Jones verliert mittags (finanzen.at) | |
14.02.25 |
Minuszeichen in New York: Dow Jones verliert zum Start des Freitagshandels (finanzen.at) | |
11.02.25 |
Schwache Performance in New York: Dow Jones zum Handelsstart in Rot (finanzen.at) | |
10.02.25 |
Dow Jones 30 Industrial-Titel Amgen-Aktie: So viel hätten Anleger mit einem Investment in Amgen von vor 3 Jahren verdient (finanzen.at) | |
05.02.25 |
Börse New York in Grün: NASDAQ 100 zum Ende des Mittwochshandels mit Kursplus (finanzen.at) |
Analysen zu Amgen Inc.mehr Analysen
Aktien in diesem Artikel
Amgen Inc. | 280,60 | 0,43% |
|
Indizes in diesem Artikel
NASDAQ Comp. | 20 053,29 | 0,06% | |
S&P 500 | 6 132,64 | 0,05% | |
NASDAQ 100 | 22 175,00 | 0,05% | |
S&P 100 | 2 997,57 | 0,13% |